Subtype
Benign Pericytic Neoplasm
CI-CAN-00000531Explore in graph →
Non-malignant1 active trials1 evidence items
- NCIt
- C6529
Loading cancer entity…
Subtype
CI-CAN-00000531Explore in graph →
Clinical trials
4 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03899792 | A Study of Oral LOXO-292 (Selpercatinib) in Pediatric Participants With Advanced Solid or Primary Central Nervous System (CNS) Tumors(LIBRETTO-121) | active not recruiting | Phase 1 / Phase 2 | 36 | Eli Lilly and CompanyINDUSTRY | 11 | Jan 6, 2026 | clinicaltrials |
| NCT06497283 | Binaural Sound for Remimazolam Maintenance | unknown | N/A | 72 | Gangnam Severance HospitalOTHER | 1 | Aug 9, 2024 | clinicaltrials |
| NCT04990076 | Ultrasound Evaluation of the Myometrium Using the MUSA Terminology Comparison With Histology(MUSA1) | unknown | — | 1,500 | Universitaire Ziekenhuizen KU LeuvenOTHER | 1 | Jul 3, 2024 | clinicaltrials |
| NCT05126420 |
Data updated 22 days agoSource updated Jan 6, 2026source: clinicaltrials
| MIYOPERİCYTOMA OF ORAL MUCOSE: CASE REPORT |
| completed |
| — |
| 1 |
| Ankara UniversityOTHER |
| 1 |
| Nov 19, 2021 |
| clinicaltrials |